Found 15 Enz. Inhib. hit(s) with Target = 'Guanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2' TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 11.8nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 52.9nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 8nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 51nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 21.7nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 12.7nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 10.1nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 17.8nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 17.2nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 10.3nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 82.3nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 32.3nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 13.2nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 11.3nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
TargetGuanine nucleotide-binding protein subunit alpha-15 [Y147C]/N-formyl peptide receptor 2(Homo sapiens (Human))
Actelion Pharmaceuticals, LTD.
US Patent
Actelion Pharmaceuticals, LTD.
US Patent
Affinity DataEC50: 7.60nMAssay Description:Cells expressing recombinant human ALX receptor and the G-protein Gα16 (HEK293-hALXR-Gα16) were grown to 80% confluency in Growing Medium (...More data for this Ligand-Target Pair
